New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For C;BA;BAC;BLK;NUS;KSWS;CBS;CLSN;WSM;PWER;AB From The Last 14 Days
Check below for free stories on C;BA;BAC;BLK;NUS;KSWS;CBS;CLSN;WSM;PWER;AB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 9, 2014
13:49 EDTBABoeing, Air Canada sign agreement for Boeing Maintenance Performance Toolbox
Boeing (BA) announced that Air Canada (AIDIF) has signed an agreement to implement the Boeing Maintenance Performance Toolbox to support maintenance operations for its 767, 777, 787 and 737 MAX airplane fleets. The Maintenance Performance Toolbox suite delivers access to information that technicians need to resolve airplane maintenance issues. As part of the Toolbox deployment project, Boeing will also provide services for transition and migration of customized data from maintenance management applications currently used by Air Canada, and will enable integration with existing maintenance resource planning systems.
13:37 EDTBACBank of America ordered by CFPB to pay $727M for illegal credit card practices
Subscribe for More Information
12:24 EDTBACBank of America to pay $800M in credit card settlement, WSJ says
Subscribe for More Information
08:48 EDTBACHuntington Bancshares to acquire 11 branches in central, east Michigan
Subscribe for More Information
08:03 EDTCLSNCelsion announces data supporting development of ThermoDox
Celsion announced that data supporting the development of ThermoDox, its proprietary heat-activated liposomal encapsulation of doxorubicin, plus high intensity focused ultrasound were presented at the International Symposium on Therapeutic Ultrasound. Mark Dewhirst, D.V.M., Ph.D. presented data demonstrating the potential of ThermoDox plus HIFU to maximize drug delivery to the targeted tumor site. Celsion is exploring the potential of ThermoDox in combination with HIFU as a non-invasive treatment for a variety of cancers, including pancreatic cancer, Glioblastoma Multiforme, metastatic liver cancer, and breast cancer.
07:41 EDTBACBofA unit, Allstate dismiss toxic mortgage debt suit, Reuters says
Allstate (ALL) and Bank of America's (BAC) Countrywide unit have agreed to end a lawsuit stemming from $700M of toxic mortgage debt, according to Reuters, citing a court filing. Reference Link
07:18 EDTCLevy Economics Institute to hold a conference
Subscribe for More Information
07:00 EDTBACBofA, Intel fire 3K workers, leaving Costa Rica shocked, Bloomberg says
Subscribe for More Information
06:35 EDTBAC, CRegulators increase leverage ratio requirement for large banks, NY Times says
Subscribe for More Information
06:27 EDTBAC, CBig banks must add capital to comply with new rules, WSJ reports
A of January 1, 2018, the U.S.'s eight largest banks -- including Citigroup (C), JPMorgan (JPM) and Goldman Sachs (GS) -- must add up to $68B in extra capital to comply with a new rule intended to help firms weather losses during periods of market stress, the Wall Street Journal. The banks will be required to maintain well above the minimum levels of capital held against assets on their books. Banks must report the new levels next year. Reference Link
06:18 EDTCEgan-Jones, Glass Lewis oppose Citigroup's pay proposal, WSJ reports
Subscribe for More Information
April 8, 2014
16:01 EDTCApple Netflix Citigroup Tesla Banco Santander Alcoa
Subscribe for More Information
09:35 EDTCActive equity options trading on open
Subscribe for More Information
06:41 EDTCCitigroup plans to close one third of Korea branches, Reuters says
Citigroup announced that it is planning to close nearly one third of its Korea branches, which makes it the third global bank to reduce its presence in the country in the last year due to increasing expenses and intense competition, according to Reuters, citing a statement from the bank. Reference Link
06:24 EDTCCitigroup may miss return-on-tangible-common-equity goal, WSJ reports
According to sources, Citigroup may miss a its 2015 target for return-on-tangible-common-equity after the Federal Reserve last month rejected the bank's capital plan, the Wall Street Journal reports. The Fed denied Citigroup's proposal to boost its dividend and increase stock buybacks on March 26, making it unlikely Citigroup can meet this key profitability target. Reference Link
April 7, 2014
19:57 EDTC, BACFederal Reserve announces extension on some CLOs
The Federal Reserve Board announced that it intends to exercise its authority to give banking entities two additional one-year extensions to conform their ownership interests in and sponsorship of certain collateralized loan obligations, or CLOs, covered by section 619 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, commonly referred to as the Volcker rule. Section 619 of the Dodd-Frank Act directed the board to adopt rules for the conformance period and the board previously extended the conformance period for all activities and investments by one year to July 21, 2015. To ensure effective compliance, the board intends to grant banking entities two additional one-year extensions, which together would extend until July 21, 2017, to conform their ownership interests in and sponsorship of CLOs to the statute. Publicly traded companies that may be impacted by the announcement include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
17:16 EDTCCitigroup to resolve certain private-label securitization repurchase claims
Subscribe for More Information
16:01 EDTCOptions Update; April 7, 2014
Subscribe for More Information
12:21 EDTBABoeing now sees completing C-17 production in mid-2015
Boeing adjusted slightly the timing for ending C-17 Globemaster III production and closing its Long Beach, Calif., C-17 final assembly facility after a successful two-decade production run of the world's premier airlifter.Based on current market trends and the timing of expected orders, Boeing anticipates completing C-17 production in mid-2015, an adjustment of approximately three months from an initial estimate of late 2015. The company announced plans to end C-17 production in September 2013. Boeing expects inventory–related charges of approximately $50M, which will be recorded in Q1, as a result of this announcement.
10:00 EDTCOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use